Antivascular endothelial growth factor agents pretreatment before vitrectomy for complicated proliferative diabetic retinopathy: a meta-analysis of randomised controlled trials

BACKGROUND/AIMS: To evaluate the efficacy of antivascular endothelial growth factor (anti-VEGF) agents pretreatment before vitrectomy for patients with complicated proliferative diabetic retinopathy (PDR). METHODS: The PubMed, Embase and the Cochrane Central Register of Controlled Trials were search...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Br J Ophthalmol
Egile Nagusiak: Zhao, Xin-yu, Xia, Song, Chen, You-xin
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Publishing Group 2018
Gaiak:
Clinical Science
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6059039/
https://ncbi.nlm.nih.gov/pubmed/29246890
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjophthalmol-2017-311344
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak